Literature DB >> 15128504

Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles.

Nayoung Kim1, Weibiao Cao, In Sung Song, Chung Yong Kim, Karen M Harnett, Ling Cheng, Michael P Walsh, Piero Biancani.   

Abstract

Contraction of smooth muscle depends on the balance of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities. Because MLCK activation depends on the activation of calmodulin, which requires a high Ca(2+) concentration, phosphatase inhibition has been invoked to explain contraction at low cytosolic Ca(2+) levels. The link between activation of the Ca(2+)-independent protein kinase Cepsilon (PKCepsilon) and MLC phosphorylation observed in the esophagus (ESO) (Sohn UD, Cao W, Tang DC, Stull JT, Haeberle JR, Wang CLA, Harnett KM, Behar J, and Biancani P. Am J Physiol Gastrointest Liver Physiol 281: G467-G478, 2001), however, has not been elucidated. We used phosphatase and kinase inhibitors and antibodies to signaling enzymes in combination with intact and saponin-permeabilized isolated smooth muscle cells from ESO and lower esophageal sphincter (LES) to examine PKCepsilon-dependent, Ca(2+)-independent signaling in ESO. The phosphatase inhibitors okadaic acid and microcystin-LR, as well as an antibody to the catalytic subunit of type 1 protein serine/threonine phosphatase, elicited similar contractions in ESO and LES. MLCK inhibitors (ML-7, ML-9, and SM-1) and antibodies to MLCK inhibited contraction induced by phosphatase inhibition in LES but not in ESO. The PKC inhibitor chelerythrine and antibodies to PKCepsilon, but not antibodies to PKCbetaII, inhibited contraction of ESO but not of LES. In ESO, okadaic acid triggered translocation of PKCepsilon from cytosolic to particulate fraction and increased activity of integrin-linked kinase (ILK). Antibodies to the mitogen-activated protein (MAP) kinases ERK1/ERK2 and to ILK, and the MAP kinase kinase (MEK) inhibitor PD-98059, inhibited okadaic acid-induced ILK activity and contraction of ESO. We conclude that phosphatase inhibition potentiates the effects of MLCK in LES but not in ESO. Contraction of ESO is mediated by activation of PKCepsilon, MEK, ERK1/2, and ILK.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128504     DOI: 10.1152/ajpcell.00390.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  9 in total

1.  Muscarinic m2 receptor-mediated actin polymerization via PI3 kinase γ and integrin-linked kinase in gastric smooth muscle.

Authors:  Sunila Mahavadi; John R Grider; Karnam S Murthy
Journal:  Neurogastroenterol Motil       Date:  2018-11-04       Impact factor: 3.598

Review 2.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

3.  Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle.

Authors:  Lori D Moffat; Shannon B A Brown; Michael E Grassie; Annegret Ulke-Lemée; Laura M Williamson; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 4.  RhoA/Rho-kinase: pathophysiologic and therapeutic implications in gastrointestinal smooth muscle tone and relaxation.

Authors:  Satish Rattan; Benjamin R Phillips; Pinckney J Maxwell
Journal:  Gastroenterology       Date:  2009-11-23       Impact factor: 22.682

5.  Jun kinase-induced overexpression of leukemia-associated Rho GEF (LARG) mediates sustained hypercontraction of longitudinal smooth muscle in inflammation.

Authors:  Othman Al-Shboul; Ancy D Nalli; Divya P Kumar; Ruizhe Zhou; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

6.  Differential expression of multidrug resistance protein 5 and phosphodiesterase 5 and regulation of cGMP levels in phasic and tonic smooth muscle.

Authors:  Othman Al-Shboul; Sunila Mahavadi; Wimolpak Sriwai; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-13       Impact factor: 4.052

7.  Gi-coupled receptors mediate phosphorylation of CPI-17 and MLC20 via preferential activation of the PI3K/ILK pathway.

Authors:  Jiean Huang; Sunila Mahavadi; Wimolpak Sriwai; Wenhui Hu; Karnam S Murthy
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

Review 8.  Opportunities to Target Specific Contractile Abnormalities with Smooth Muscle Protein Kinase Inhibitors.

Authors:  Annegret Ulke-Lemée; Justin A MacDonald
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-26

Review 9.  Calcium Sensitization Mechanisms in Gastrointestinal Smooth Muscles.

Authors:  Brian A Perrino
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.